Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$951M |
| 2 |
Advanced Micro Devices
AMD
|
+$589M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$418M |
| 4 |
Lam Research
LRCX
|
+$412M |
| 5 |
Microsoft
MSFT
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$585M |
| 3 |
STMP
Stamps.com, Inc.
STMP
|
+$111M |
| 4 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$87.8M |
| 5 |
TSMC
TSM
|
+$70.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.05% |
| 2 | Financials | 11.79% |
| 3 | Healthcare | 10.9% |
| 4 | Consumer Discretionary | 10.36% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
United Microelectronic
UMC
$48.2B
| $1.23M | ﹤0.01% |
107,478
+17,425
| +19% | +$187K |
|
527
Ford
F
$55B
| $1.23M | ﹤0.01% |
86,562
+22,745
| +36% | +$309K |
|
528
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.4B
| $1.21M | ﹤0.01% |
22,716
-20,320
| -47% | -$1.09M |
|
529
iShares S&P 100 ETF
OEF
$20.5B
| $1.19M | ﹤0.01% |
6,018
-147
| -2% | -$29.9K |
|
530
PetMed Express
PETS
$42.1M
| $1.19M | ﹤0.01% |
44,218
-4,683
| -10% | -$135K |
|
|
ESTE
531
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $1.17M | ﹤0.01% |
127,647
+27,782
| +28% | +$255K |
|
532
Philip Morris
PM
$293B
| $1.17M | ﹤0.01% |
12,363
-2,406
| -16% | -$242K |
|
533
Pacira BioSciences
PCRX
$1.02B
| $1.16M | ﹤0.01% |
20,787
+4,847
| +30% | +$279K |
|
534
Boot Barn
BOOT
$4.97B
| $1.14M | ﹤0.01% |
12,811
+3,107
| +32% | +$268K |
|
535
Labcorp
LH
$25.6B
| $1.14M | ﹤0.01% |
4,710
+62
| +1% | +$15.6K |
|
536
Ironwood Pharmaceuticals
IRWD
$701M
| $1.12M | ﹤0.01% |
85,918
-16,706
| -16% | -$216K |
|
|
HOLX
537
DELISTED
Hologic
HOLX
| $1.12M | ﹤0.01% |
15,193
-294
| -2% | -$22K |
|
538
Parker-Hannifin
PH
$135B
| $1.11M | ﹤0.01% |
3,969
| – | – |
|
|
JNPR
539
DELISTED
Juniper Networks
JNPR
| $1.09M | ﹤0.01% |
39,638
+508
| +1% | +$14.3K |
|
540
W&T Offshore
WTI
$497M
| $1.09M | ﹤0.01% |
292,742
+74,437
| +34% | +$266K |
|
541
Resources Connection
RGP
$145M
| $1.08M | ﹤0.01% |
68,346
+8,671
| +15% | +$130K |
|
|
CPRX
542
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.07M | ﹤0.01% |
+201,801
| New | +$1.1M |
|
543
Banner Corp
BANR
$2.4B
| $1.07M | ﹤0.01% |
19,318
+5,146
| +36% | +$277K |
|
544
Kroger
KR
$35.1B
| $1.06M | ﹤0.01% |
26,272
+438
| +2% | +$18.4K |
|
545
Weyerhaeuser
WY
$18.3B
| $1.06M | ﹤0.01% |
29,858
-666
| -2% | -$23.3K |
|
546
Quanex
NX
$959M
| $1.05M | ﹤0.01% |
49,198
+11,339
| +30% | +$265K |
|
547
iShares ESG Aware MSCI EAFE ETF
ESGD
$12.2B
| $1.05M | ﹤0.01% |
13,420
+1,113
| +9% | +$89.4K |
|
548
Ligand Pharmaceuticals
LGND
$6.02B
| $1.04M | ﹤0.01% |
11,917
+1,909
| +19% | +$148K |
|
549
Old Dominion Freight Line
ODFL
$44B
| $1.03M | ﹤0.01% |
7,210
+166
| +2% | +$23K |
|
550
State Street SPDR S&P Capital Markets ETF
KCE
$466M
| $1.02M | ﹤0.01% |
10,719
-133
| -1% | -$12.8K |
|
Similar funds
Ken Fisher's Q3 2021 Portfolio in Review
As of Q3 2021, Ken Fisher held 1,103 positions worth $161B, up 1.1% from $159B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q3 2021 filing shows 93 new, 444 increased, 375 reduced and 75 closed positions. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M. The largest sale was Visa, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q3 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M.
- Ken Fisher added most to Meta Platforms (Facebook) in Q3 2021, an estimated $951M increase.
- Ken Fisher's biggest Q3 2021 reduction was Visa, cutting an estimated $1.24B.
- Ken Fisher fully exited Stamps.com, Inc. in Q3 2021, selling an estimated $111M.
- Ken Fisher's ten largest holdings make up 31% of its $161B portfolio in Q3 2021.
- Ken Fisher opened 93 new positions and closed 75 in Q3 2021.
- Ken Fisher's portfolio value rose 1.1% quarter-over-quarter to $161B.
Based on Fisher Asset Management's 13F filing for Q3 2021, filed 26 Oct 2021.